Table 20-10.

Quality of Care by Race/Ethnicity and Sex in the GWTG-HF Program, 2009

	Race/Ethnicity			Sex
Quality-of-Care Measure	White	Black	Hispanic	Men	Women
Complete set of discharge instructions*	90.8	91.7	91.4	91.3	90.2
Measure of LV function*	98.3	98.9	97.3	98.4	98.0
ACEI or ARB at discharge for patients with LVSD, no contraindications*	92.0	94.2	94.0	92.8	93.0
Smoking cessation counseling, current smokers*	96.6	99.1	96.7	97.8	97.1
β-Blockers at discharge for patients with LVSD, no contraindications*	92.8	92.0	91.2	93.2	92.0
Hydralazine/nitrates at discharge for patients with LVSD, no contraindications	NM	12.2	NM	13.1†	10.1†
Anticoagulation for atrial fibrillation or atrial flutter, no contraindications	69.2	67.2	72.3	71.6	66.1
Composite quality-of-care measure‡	94.4	95.1	94.0	94.7	94.2

GWTG-HF indicates Get With The Guidelines–Heart Failure; LV, left ventricular; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVSD, left ventricular systolic dysfunction; NM, not measured.

Values are percentages.

^*Indicates the 5 key achievement measures targeted in GWTG-HF.

^†For black patients only.

^‡The composite quality-of-care measure indicates performance on the provision of several elements of care. It is computed by summing the numerators for each key achievement measure across the population of interest to create a composite numerator (all the care that was given), summing the denominators for each measure to form a composite denominator (all the care that should have been given), and reporting the ratio (the percentage of all the needed care that was given).